Detection of MTRR 66A→G polymorphism using the real‐time polymerase chain reaction machine LightCycler for determination of composition of allele after restriction cleavage

References

• Cooper D. N., Smith B. A., Cooke H. J., Niemann S., Schmidtke J. An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet 1985; 69: 201–5
   PubMed Web of Science ®Google Scholar
• Ford E. S., Smith S. J., Stroup D. F., Steinberg K. K., Mueller P. W., Thacker S. B. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case‐control studies and nested case‐control studies. Int J Epidemiol 2002; 31: 59–70
   PubMed Web of Science ®Google Scholar
• Folate status: modulation of colorectal carcinogenesis. Homocysteine metabolism: from basic science to clinical medicine, I Graham, H Refsum, I. H Rosenberg, P Ueland. Kluwer Academic Publishers, Amsterdam 1997; 167–76
   Google Scholar
• Hobbs C. A., Sherman S. L., Yi P., Hopkins S. E., Torfs C. P., Hine R. J., et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000; 67: 623–30
   PubMed Web of Science ®Google Scholar
• Refsum H., Ueland P. M., Nygard O., Vollset S. E. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31–62
   PubMed Web of Science ®Google Scholar
• Wilson A., Platt R., Wu Q., Leclerc D., Christensen B., Yang H., et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999; 67: 317–23
   PubMed Web of Science ®Google Scholar
• Gueant‐Rodriguez R. M., Rendeli C., Namour B., Venuti L., Romano A., Anello G., et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003; 344: 189–92
   PubMed Web of Science ®Google Scholar
• Gaustadnes M., Rudiger N., Rasmussen K., Ingerslev J. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants. Thromb Haemost 2000; 83: 554–8
   PubMed Web of Science ®Google Scholar
• Lievers K. J., Kluijtmans L. A., Blom H. J. Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann Clin Biochem 2003; 40: 46–59
   PubMedGoogle Scholar
• Leclerc D., Odievre M., Wu Q., Wilson A., Huizenga J. J., Rozen R., et al. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. Gene 1999; 240: 75–88
   PubMed Web of Science ®Google Scholar
• O'Leary V. B., Parle‐McDermott A., Molloy A. M., Kirke P. N., Johnson Z., Conley M., et al. MTRR and MTHFR polymorphism: link to Down syndrome?. Am J Med Genet 2002; 107: 151–5
   PubMed Web of Science ®Google Scholar
• Bosco P., Gueant‐Rodriguez R. M., Anello G., Barone C., Namour F., Caraci F., et al. Methionine synthase (MTR) 2756 (A−>G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003; 121: 219–24
   Google Scholar
• Zhu H., Wicker N. J., Shaw G. M., Lammer E. J., Hendricks K., Suarez L., et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 2003; 78: 216–21
   PubMed Web of Science ®Google Scholar
• Gemmati D., Ongaro A., Scapoli G. L., Della P. M., Tognazzo S., Serino M. L., et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non‐Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787–94
   PubMed Web of Science ®Google Scholar
• Olteanu H., Munson T., Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002; 41: 13378–85
   PubMed Web of Science ®Google Scholar
• Rady P. L., Szucs S., Grady J., Hudnall S. D., Kellner L. H., Nitowsky H., et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002; 107: 162–8
   PubMed Web of Science ®Google Scholar
• Gaughan D. J., Kluijtmans L. A., Barbaux S., McMaster D., Young I. S., Yarnell J. W., et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001; 157: 451–6
   PubMed Web of Science ®Google Scholar
• Gaughan D. J., Kluijtmans L. A., Barbaux S., McMaster D., Young I. S., Yarnell J. W., et al. Corrigendum to “The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations” [Atherosclerosis 2001;157:451–6]. Atherosclerosis 2003; 167: 373
   Google Scholar
• Relton C. L., Wilding C. S., Pearce M. S., Laffling A. J., Jonas P. A., Lynch S. A., et al. Gene–gene interaction in folate‐related genes and risk of neural tube defects in a UK population. J Med Genet 2004; 41: 256–60
   PubMed Web of Science ®Google Scholar
• Relton C. L., Wilding C. S., Laffling A. J., Jonas P. A., Burgess T., Binks K., et al. Low erythrocyte folate status and polymorphic variation in folate‐related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 2004; 81: 273–81
   PubMed Web of Science ®Google Scholar
• Geisel J., Zimbelmann I., Schorr H., Knapp J. P., Bodis M., Hubner U., et al. Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 2001; 39: 698–704
   PubMed Web of Science ®Google Scholar
• Ray J. G., Langman L. J., Vermeulen M. J., Evrovski J., Yeo E. L., Cole D. E. Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med 2001; 2: 141–9
   PubMedGoogle Scholar
• Shi M., Caprau D., Romitti P., Christensen K., Murray J. C. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol 2003; 67: 545–9
   PubMedGoogle Scholar
• Brown C. A., McKinney K. Q., Kaufman J. S., Gravel R. A., Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 2000; 7: 197–200
   PubMedGoogle Scholar
• Kiffmeyer W. R., Langer E., Davies S. M., Envall J., Robison L. L., Ross J. A. Genetic polymorphisms in the Hmong population: implications for cancer etiology and survival. Cancer 2004; 100: 411–7
   PubMed Web of Science ®Google Scholar
• Zijno A., Andreoli C., Leopardi P., Marcon F., Rossi S., Caiola S., et al. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 2003; 24: 1097–103
   PubMedGoogle Scholar
• Jacques P. F., Bostom A. G., Selhub J., Rich S., Ellison R. C., Eckfeldt J. H., et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 2003; 166: 49–55
   PubMed Web of Science ®Google Scholar